Claritev Corporation(CTEV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CTEV Claritev Corporation

Trading 10-02 10:15:15 EDT

21.80

+0.49

+2.30%

High21.94	Low21.36	Vol26.06K
Open21.92	D1 Closing21.31	Amplitude2.72%
Mkt Cap369.88M	Tradable Cap123.64M	Total Shares16.97M
T/O561.77K	T/O Rate0.46%	Tradable Shares5.67M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CTEV","market":"US","secType":"STK","nameCN":"Claritev Corporation","latestPrice":21.8,"timestamp":1790950503032,"preClose":21.31,"halted":0,"volume":26055,"delay":0,"changeRate":0.022993899577663162,"floatShares":5671700,"shares":16966900,"eps":-16.987898,"marketStatus":"Trading","change":0.49,"latestTime":"10-02 10:15:15 EDT","open":21.92,"high":21.94,"low":21.36,"amount":561774.121785,"amplitude":0.027217,"askPrice":22.07,"askSize":2,"bidPrice":21.57,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-16.987898,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790971200000},"marketStatusCode":2,"adr":0,"exchange":"NYSE","adjPreClose":21.31,"preHourTrading":{"tag":"盘前","latestPrice":21.28,"preClose":21.31,"latestTime":"07:58 EDT","volume":10,"amount":212.8,"timestamp":1790942302513,"change":-0.03,"changeRate":-0.001408,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":21.31,"preClose":21.31,"latestTime":"19:30 EDT","volume":9877,"amount":210478.87,"timestamp":1790897405089,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.156203,"impliedVol":1.1805,"impliedVolPercentile":0.6534},"requestUrl":"/m/hq/s/CTEV/wiki","defaultTab":"wiki","newsList":[{"id":"2669122153","title":"Claritev EVP, CFO Douglas Michael Garis Sells USD 276,009 of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2669122153","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669122153?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:31","pubTimestamp":1790109099,"startTime":"0","endTime":"0","summary":"Claritev EVP, CFO Douglas Michael Garis sells USD 276,009 of common sharesClaritev EVP and CFO Douglas Michael Garis sold 9,025 Class A common shares on Sep. 21, 2026.Sales priced at USD 30.5 and USD ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL2sZ1gd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Claritev EVP, CFO Douglas Michael Garis Sells USD 276,009 of Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669422551","title":"Claritev Selected by GDIT to Support CDC World Trade Center Health Program Provider Network","url":"https://stock-news.laohu8.com/highlight/detail?id=2669422551","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669422551?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:04","pubTimestamp":1790082281,"startTime":"0","endTime":"0","summary":"Claritev selected by GDIT to support CDC World Trade Center Health Program provider networkClaritev was selected by GDIT to support the CDC’s World Trade Center Health Program under the James Zadroga ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL1xhH95:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669946142","title":"Claritev Corp - to Administer Nationwide Provider Network for Wtc Health Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2669946142","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669946142?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082024,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nFWN45E0N2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WDGF","BK4167","BK4566","BK4550","CTEV","GD","IDEF","FOWF","LU0170899867.USD","BK4588","SHLD","BK4516","BK4187","PPA","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142999","title":"Claritev Corp - Selected by Gdit to Support World Trade Center Health Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142999","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142999?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082024,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nFWN45E0N2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","BK4585","GD","IDEF","LU0170899867.USD","BK4550","BK4588","SHLD","BK4566","BK4516","CTEV","PPA","BK4187","WDGF","FOWF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668967991","title":"Claritev Announces Availability of 2025 Corporate Responsibility Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2668967991","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668967991?lang=en_us&edition=fundamental","pubTime":"2026-09-17 21:01","pubTimestamp":1789650061,"startTime":"0","endTime":"0","summary":"Claritev announces availability of 2025 Corporate Responsibility ReportClaritev published its 2025 Corporate Responsibility Report outlining progress on responsible AI, employee engagement, community ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDLB6lkJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668212933","title":"Claritev Files Form 3 as Director Thomas Benjamin Letham Reports no Beneficial Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2668212933","media":"Reuters","labels":["executive","shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668212933?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:18","pubTimestamp":1789589900,"startTime":"0","endTime":"0","summary":"Claritev files Form 3 as director Thomas Benjamin Letham reports no beneficial ownershipClaritev named Thomas Benjamin Letham as a director in an initial Form 3 filing dated 09/14/2026.Disclaimer:This","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL6YVg4p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667641983","title":"Claritev Targets Faster Solution Rollout with Technology Modernization, AI Readiness Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2667641983","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667641983?lang=en_us&edition=fundamental","pubTime":"2026-09-16 20:24","pubTimestamp":1789561485,"startTime":"0","endTime":"0","summary":"Claritev targets faster solution rollout with technology modernization, AI readiness pushClaritev outlined a forward strategy centered on technology modernization to scale faster across healthcare ami","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL5wydrC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667405046","title":"Claritev appoints Letham to its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667405046","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667405046?lang=en_us&edition=fundamental","pubTime":"2026-09-15 21:21","pubTimestamp":1789478460,"startTime":"0","endTime":"0","summary":"Claritev (CTEV) announced that its Board of Directors has appointed Ben Letham as a director, effective September 14, 2026, to fill a vacancy on th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/claritev-appoints-letham-to-its-board-of-directors-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/claritev-appoints-letham-to-its-board-of-directors-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667647112","title":"Claritev Appoints Ben Letham to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667647112","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667647112?lang=en_us&edition=fundamental","pubTime":"2026-09-15 21:00","pubTimestamp":1789477208,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nTUA8LQXHC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666953828","title":"Claritev Says Healthcare Pricing Intelligence Turns Transparency Data into Operational Cost-Management Tool","url":"https://stock-news.laohu8.com/highlight/detail?id=2666953828","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666953828?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:15","pubTimestamp":1788956117,"startTime":"0","endTime":"0","summary":"Claritev says healthcare pricing intelligence turns transparency data into operational cost-management toolClaritev published a strategic market analysis on Sep. 9, 2026, outlining how pricing intelli","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL24Hsp1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663030170","title":"Claritev CEO and Executive Chair Dalton Travis Reports $249,909 Purchase of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2663030170","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663030170?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:50","pubTimestamp":1788180655,"startTime":"0","endTime":"0","summary":"Claritev CEO and Executive Chair Dalton Travis reports $249,909 purchase of common sharesClaritev President, CEO, Executive Chair, director Dalton Travis reported open-market purchases of Class A comm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL2G3GP4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Claritev CEO and Executive Chair Dalton Travis Reports $249,909 Purchase of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662581702","title":"Claritev Management to Present at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662581702","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662581702?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:01","pubTimestamp":1787832103,"startTime":"0","endTime":"0","summary":"Claritev management to present at Morgan Stanley global healthcare conferenceClaritev management will meet investors at the Wells Fargo 21st Annual Healthcare Conference on Sept. 9, 2026, in Boston.Sm","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL3GXMCR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242649171.HKD","LU1894683348.USD","LU0210528500.USD","LU2456880835.USD","IYG","LU0149725797.USD","LU0256863902.USD","LU1116320737.USD","LU1119994496.HKD","FTXO","IAI","IE00BJLML261.HKD","LU0820561818.USD","LU2746668974.SGD","TFNS","LU0106261372.USD","LU0234570918.USD","LU0158827781.USD","LU2552382058.USD","CTEV","VFH","LU0795875086.SGD","LU1074936037.SGD","LU0256863811.USD","JPO","LU0187121727.USD","IXG","LU1280957306.USD","LU1668664300.SGD","LU2237443622.USD","LU0868494708.USD","LU2023250330.USD","LU2430703095.HKD","JPMO","KBWB","LU1732800096.USD","LU2054465674.USD","LU2237443382.USD","IE00B1BXHZ80.USD","LU0225283273.USD","UYG","IYF","LU0323591593.USD","TRUF","LU1974910355.USD","IE00BLSP4452.SGD","XLF","IE000M9KFDE8.USD","FNCL","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250734","title":"U.S. Research Roundup-Health Catalyst, Nektar Therapeutics, TIC Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250734","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250734?lang=en_us&edition=fundamental","pubTime":"2026-08-21 15:26","pubTimestamp":1787297213,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Health Catalyst, Nektar Therapeutics, TIC SolutionsAug 21 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, incl","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL8N44I09H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTAI","IMA","ECG","TRFK","INNV","DISK","MRVL","AVGU","IXN","DOCS","AMYY","LEGR","BCAL","HL","DV","PI","ADI","CHAT","AMD","FIX","GTLB","LYTS","HRZN","MATW","AVGO","HCAT","MBX","EBS","MCHP","MTSI","VEGI","QBTS","CTEV","FERG","AAP","ADSK","FTH","BAI","MU","BWMN","EGGY","P","SMHX","ACEL","LMB","APP","COTY","ABT","AMP","DE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661902236","title":"Claritev price target raised to $40 from $28 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2661902236","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661902236?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:30","pubTimestamp":1787243412,"startTime":"0","endTime":"0","summary":"Barclays analyst Glen Santangelo raised the firm’s price target on Claritev (CTEV) to $40 from $28 and keeps an Overweight rating on the shares. Pu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/claritev-price-target-raised-to-40-from-28-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/claritev-price-target-raised-to-40-from-28-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660978054","title":"Claritev Chief Growth Officer Tiffani Misencik Sells 8,850 Shares Worth $354,592.95","url":"https://stock-news.laohu8.com/highlight/detail?id=2660978054","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660978054?lang=en_us&edition=fundamental","pubTime":"2026-08-19 05:08","pubTimestamp":1787087285,"startTime":"0","endTime":"0","summary":"Claritev Chief Growth Officer Tiffani Misencik sells 8,850 shares worth $354,592.95Tiffani Misencik, SVP and Chief Growth Officer, sold 8,850 shares of Class A common stock on Aug. 14, 2026.Sale price","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL6k9k4C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Claritev Chief Growth Officer Tiffani Misencik Sells 8,850 Shares Worth $354,592.95","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660462560","title":"Claritev Shifts Payment Integrity Strategy Toward Pre-Pay Overpayment Prevention to Boost ROI","url":"https://stock-news.laohu8.com/highlight/detail?id=2660462560","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660462560?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:06","pubTimestamp":1787054801,"startTime":"0","endTime":"0","summary":"Claritev shifts payment integrity strategy toward pre-pay overpayment prevention to boost ROIClaritev outlined a shift in payment integrity toward pre-payment prevention, aiming to reduce improper pay","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL8TbdhV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660480741","title":"Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients","url":"https://stock-news.laohu8.com/highlight/detail?id=2660480741","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660480741?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:02","pubTimestamp":1786971759,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nFWN44E0VD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTEV","MRAI","BK4167","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660480718","title":"Claritev Expands Marpai Partnership to Add Pre- and Post-Payment Claims Integrity Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2660480718","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660480718?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:01","pubTimestamp":1786971667,"startTime":"0","endTime":"0","summary":"Claritev expands Marpai partnership to add pre- and post-payment claims integrity servicesClaritev expanded its relationship with Marpai to provide pre- and post-payment integrity services across clai","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL69NhTD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","MRAI","BK4173","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659121490","title":"Multiplan Board Authorizes Management to Proceed with Annual Business Plan Implementation","url":"https://stock-news.laohu8.com/highlight/detail?id=2659121490","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659121490?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:01","pubTimestamp":1786741316,"startTime":"0","endTime":"0","summary":"Multiplan board authorizes management to proceed with annual business plan implementationMultiplan’s board met Aug. 6, 2026 to review business performance, project execution, strategic priorities.Dire","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL1TKwVS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900686","title":"Claritev SVP, Chief Strategy Officer William B. Mintz Sells 8,431 Common Shares for $288,277.44","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900686","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900686?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:14","pubTimestamp":1786565673,"startTime":"0","endTime":"0","summary":"Claritev SVP, Chief Strategy Officer William B. Mintz sells 8,431 common shares for $288,277.44Claritev SVP, Chief Strategy Officer William B. Mintz sold 8,431 Class A common shares on Aug. 10, 2026.S","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL6PZKmT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Claritev SVP, Chief Strategy Officer William B. Mintz Sells 8,431 Common Shares for $288,277.44","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0878},{"period":"1month","weight":-0.4584},{"period":"3month","weight":-0.3471},{"period":"6month","weight":0.2205},{"period":"1year","weight":-0.5591},{"period":"ytd","weight":-0.5015}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0029},{"period":"3month","weight":0.0258},{"period":"6month","weight":0.1649},{"period":"1year","weight":0.1429},{"period":"ytd","weight":0.1204}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"MultiPlan is committed to helping healthcare payors manage the cost of care, improve their competitiveness and inspire positive change. Leveraging sophisticated technology, data analytics, and a team rich with industry experience, MultiPlan interprets clients' needs and customizes innovative solutions that combine its payment integrity, network-based and analytics-based services. MultiPlan is a trusted partner to over 700 healthcare payors in the commercial health, dental, government and property and casualty markets. For more information, visit multiplan.com.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.061926},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.109417},{"month":3,"riseRate":0.5,"avgChangeRate":-0.000837},{"month":4,"riseRate":0.5,"avgChangeRate":0.097586},{"month":5,"riseRate":0.857143,"avgChangeRate":0.184077},{"month":6,"riseRate":0.857143,"avgChangeRate":0.150237},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.077934},{"month":8,"riseRate":0.428571,"avgChangeRate":0.050377},{"month":9,"riseRate":0,"avgChangeRate":-0.180343},{"month":10,"riseRate":0.714286,"avgChangeRate":-0.015282},{"month":11,"riseRate":0,"avgChangeRate":-0.185403},{"month":12,"riseRate":0.666667,"avgChangeRate":0.131872}],"exchange":"NYSE","name":"Claritev Corporation","nameEN":"Claritev Corporation"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Claritev Corporation(CTEV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Claritev Corporation(CTEV) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Claritev Corporation,CTEV,Claritev Corporation股票,Claritev Corporation股票老虎,Claritev Corporation股票老虎国际,Claritev Corporation行情,Claritev Corporation股票行情,Claritev Corporation股价,Claritev Corporation股市,Claritev Corporation股票价格,Claritev Corporation股票交易,Claritev Corporation股票购买,Claritev Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Claritev Corporation(CTEV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Claritev Corporation(CTEV) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction